Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
<p><strong>Background</strong> Chronic kidney disease (CKD) and atrial fibrillation (AF) are increasing in prevalence globally and share common risk factors.<br> Our aim was to characterise real-world evidence on direct oral anticoagulant (DOAC) prescribing for people with A...
Main Authors: | Emanuel, S, Kaba, RA, Delanerolle, G, Field, BCT, Lip, GYH, de Lusignan, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2023
|
Similar Items
-
Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
by: Gregory Y H Lip, et al.
Published: (2023-11-01) -
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019)
by: Joy, M, et al.
Published: (2022) -
Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
by: Giuseppe Patti, et al.
Published: (2023-07-01) -
Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors
by: Vineet Kumar, et al.
Published: (2024-02-01) -
Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
by: Zhimin Dong MD, et al.
Published: (2022-12-01)